ClinicalTrials.Veeva

Menu

Comparison of Laser Destruction of Pilonidal Sinus Disease (SILAC) and Bascom II Procedure. (SI-BAS)

R

Russian Society of Colorectal Surgeons

Status

Active, not recruiting

Conditions

Pilonidal Disease

Treatments

Procedure: SiLaC
Procedure: Bascom II procedure

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Surgical treatment witn lateralization of intergluteal cleft is still gold standard for pilonidal sinus disaease. But nowadays minimally invasive treatment methods such as the use of a diode laser (SiLac, Sinus Laser Closure) to obliterate the coccygeal tract are used more often. The aim of the study is to compare a new minimal invasive method (laser treatment) with traditional method ( Bascom II) in terms of recurrence rate, complications and patients satisfaction with results.

Full description

Pilonidal sinus disease (PSD): is 26 cases per 100,000 population, affects primarily young adults. One of the problems of surgical treatment of PSD is the frequent development of recurrence. There are various methods of surgical treatment, but the recurrence rate still high up to 67%.

Nowadays, minimally invasive methods for PSD (e.g. the use of a diode laser for sinus obliteration- SiLac, Sinus Laser Closure) compete with traditional methods. This "day-surgery" method significantly reduces the risk of postoperative complications, allows a quicker return to normal daily activity, preserves the intergluteal cleft and provides the best cosmetic results. According to some authors, the recurrence rate in this method is up to 26%, parallel others- recurrence rate is less 3 %, but the follow-up does not exceed 2 years.

On the other hand, the excision of the PSD with the mobilization of the skin-subcutaneous flap, which leads to the lateralization of the postoperative scar to one side of the intergluteal cleft hereby providing a low recurrence rate (up to 4%) .

Thus, despite the increased use of minimally invasive surgery, excision of the pilonidal sinus disease cannot be undoubtedly abandoned due to the lack of comparative studies.

Enrollment

164 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  1. Written informed consent

  2. Chronic primary or recurrent pilonidal sinus at the remission stage.

  3. Presence or absence of secondary orifices.

  4. Planned surgical treatment with excision of pilonidal sinus.

  5. Location of the orifices should not be less than 1 cm.

  6. Location of secondary orifices less 2 cm from the natal cleft.

  7. Distance between bilateral symmetrical positions of secondary orifices should not be more than 2 cm.

  8. Length of the sinus in the greatest dimension, according to the ultrasound of the soft tissue of the sacrococcygeal region, should not exceed 7 cm.

  9. Sinus diameter (width) in the greatest dimension should not exceed 3 cm, according to the ultrasound of the soft tissues of the sacrococcygeal region.

  10. Sinus must be located directly under the skin, according to the ultrasound findings.

  11. Lack of fixation of the cavity to the coccyx, when evaluating data on pelvic contrast-enhanced magnetic resonance imaging (MRI)

    ____ Non-inclusion criteria

  12. Acute pilonidal sinus abscess 2. The secondary openings (orifice) position more than 3 cm from the midline. 3. Length of the cavity in the greatest dimension, according to the results of ultrasound examination, exceeds 6 cm 4. Width (diameter) of the sinus in the greatest dimension, according to the results of the ultrasound, more than 3 cm.

  13. ASA > III. 6. Predictable impossibility of following the protocol 7. Pregnancy

_____ Exclusion criteria

  1. The patients lost for the follow-up 2. The patient's refusal to continue participate in the investigation. 3. Impossibility of the operation performing in the planned scope

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

164 participants in 2 patient groups

Bascom II procedure
Active Comparator group
Description:
Pilonidal sinus is excised, subcutaneous fat and skin are closed in the lateralization with interrupted suture.
Treatment:
Procedure: Bascom II procedure
Sinus Laser Closer (SiLaC)
Active Comparator group
Description:
Pilonidal sinus is locally excised by dermopunch or scalpel, curettage of the sinus tract with laser destruction
Treatment:
Procedure: SiLaC

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems